Cingulate CING Stock
Cingulate Price Chart
Cingulate CING Financial and Trading Overview
| Cingulate stock price | 5.17 USD |
| Previous Close | 5.02 USD |
| Open | 5 USD |
| Bid | 3.63 USD x 200 |
| Ask | 6.34 USD x 200 |
| Day's Range | 4.8 - 5.17 USD |
| 52 Week Range | 3.16 - 11.89 USD |
| Volume | 69.46K USD |
| Avg. Volume | 218.93K USD |
| Market Cap | 74.02M USD |
| Beta (5Y Monthly) | -0.886 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.2 USD |
CING Valuation Measures
| Enterprise Value | 50.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.784091 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.0136175 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.079 |
Trading Information
Cingulate Stock Price History
| Beta (5Y Monthly) | -0.886 |
| 52-Week Change | 28.38% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 11.89 USD |
| 52 Week Low | 3.16 USD |
| 50-Day Moving Average | 5.03 USD |
| 200-Day Moving Average | 5.31 USD |
CING Share Statistics
| Avg. Volume (3 month) | 218.93K USD |
| Avg. Daily Volume (10-Days) | 101.93K USD |
| Shares Outstanding | 14.54M |
| Float | 14.21M |
| Short Ratio | 6.78 |
| % Held by Insiders | 28.28% |
| % Held by Institutions | 12.62% |
| Shares Short | 1.06M |
| Short % of Float | 10.11% |
| Short % of Shares Outstanding | 7.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.94% |
| Return on Equity (ttm) | -198.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -8521635 USD |
| EBITDA | -24472254 USD |
| Net Income Avi to Common (ttm) | -28809044 USD |
| Diluted EPS (ttm) | -3.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.4M USD |
| Total Cash Per Share (mrq) | 1.95 USD |
| Total Debt (mrq) | 6.29M USD |
| Total Debt/Equity (mrq) | 26.81 USD |
| Current Ratio (mrq) | 3.5 |
| Book Value Per Share (mrq) | 1.689 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20654108 USD |
| Levered Free Cash Flow (ttm) | -12838706 USD |
Profile of Cingulate
| Country | United States |
| State | KS |
| City | Kansas City |
| Address | 1901 West 47th Place |
| ZIP | 66205 |
| Phone | 913 942 2300 |
| Website | https://www.cingulate.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Q&A For Cingulate Stock
What is a current CING stock price?
Cingulate CING stock price today per share is 5.17 USD.
How to purchase Cingulate stock?
You can buy CING shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cingulate?
The stock symbol or ticker of Cingulate is CING.
Which industry does the Cingulate company belong to?
The Cingulate industry is Biotechnology.
How many shares does Cingulate have in circulation?
The max supply of Cingulate shares is 14.54M.
What is Cingulate Price to Earnings Ratio (PE Ratio)?
Cingulate PE Ratio is now.
What was Cingulate earnings per share over the trailing 12 months (TTM)?
Cingulate EPS is -3.56 USD over the trailing 12 months.
Which sector does the Cingulate company belong to?
The Cingulate sector is Healthcare.
Cingulate CING included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26186.41 USD — |
-0.56
|
6.24B USD — | 25992.55 USD — | 26329.98 USD — | — - | 6.24B USD — |
|
US Tech Health Care
IXHC
US
|
1308.52 USD — |
+1.15
|
— — | 1296.22 USD — | 1310.89 USD — | — - | — — |
- {{ link.label }} {{link}}
